Clinical Trial Detail

NCT ID NCT03460977
Title PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

lung small cell carcinoma

prostate cancer

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

PF-06821497

Age Groups: adult senior

No variant requirements are available.